drugset / Trial / NCT00941707

An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

NCT00941707

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, tolerability and safety of JNJ-38518168 compared with placebo in adult participants with active rheumatoid arthritis (long time systemic disease of the joints, marked by inflammatory changes in the synovial membranes and bones) despite methotrexate (MTX) therapy.

Timeline

Start
2010-02
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject TOREFORANT Small molecule 100 mg Oral

Indications